Vertex Pharmaceuticals Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines. | Arcturus Therapeutics Arcturus Therapeutics is a preclinical drug delivery and nucleic acid medicines company. | 4D Molecular Therapeutics 4D Molecular Therapeutics is a company focused on creation of gene therapy products to cure genetic diseases. | Spirovant Sciences Spirovant Sciences is a company focused on the development of gene therapies for treating and curing cystic fibrosis and other lung diseases. | Yumanity Therapeutics Yumanity Therapeutics (formerly known as Proteostasis Therapeutics) is a biopharmaceutical company developing therapeutics to treat diseases caused by an imbalance in the proteostasis network. | |
Founding Date | Founding Date 1989 | Founding Date 2013 | Founding Date 2013 | Founding Date 2016 | Founding Date 2014 |
Type | Type Public | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations San Diego, US HQ | Locations Emeryville, US HQ | Locations Philadelphia, US HQ | Locations Boston, US HQ | |
Employees | Employees 5,40013% increase | Employees 170 | Employees 14013% increase | Employees 32 | Employees 4434% decrease |
Valuation ($) | Valuation ($) 117.5 b | Valuation ($) 576.3 m | Valuation ($) 518.1 m | Valuation ($) N/A | Valuation ($) 15.7 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $9.9b (FY, 2023) | Revenue (est.) $166.8m (FY, 2023) | Revenue (est.) $20.7m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) $5.4m (FY, 2023) |
Net income | Net income $3.6b (FY, 2023) | Net income ($29.7m) (FY, 2023) | Net income ($100.8m) (FY, 2023) | Net income N/A | Net income ($14.1m) (FY, 2023) |
Funding | |||||
Total funding raised | Total funding raised $ 2.4m | Total funding raised N/A | Total funding raised $ 100m | Total funding raised N/A | Total funding raised $ 82m |